PARP1 and cancer: The PARP1 enzyme assay showed that the efficiency of PARP-1 inhibition by (BZP) was slightly less than that of staurosporine, while BZP-NPs inhibited the enzyme efficiently as staurosporine in MCF-7 or to a greater extent in case of MDA-MB-231 cancer cells.